← Back to list

VanEck Medical Robotics and Bionic Engineering UCITS ETF A

MVIS Global Bionic Healthcare ESG

Equities Sustainable (ESG)
ISIN
IE0005TF96I9
Issuer
VanEck
TER
0.55%
Latest closing price
N/A
Fund Size
€11 m As of: Sep 30, 2026
Domicile
Ireland
Distribution Policy
Accumulating
Replication Method
Physical
Base Currency
USD
WKN / Ticker
A3DT2R / CIB0

Data availability

Data is available for 2 of 5 areas for this fund.

  • Master data (TER, index, size): As of: Sep 30, 2026
  • Closing price: not available
  • Price history (at least 20 prices): not available
  • Holdings: As of: Jul 31, 2026
  • Risk figures: not available

Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.

At a glance

VanEck Medical Robotics and Bionic Engineering UCITS ETF A (ISIN IE0005TF96I9) is a fund from VanEck (fund type: ETF). Benchmark index: MVIS Global Bionic Healthcare ESG. Its ongoing charges (TER) are 0.55% per year. The fund size is €11 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Ireland.

Key Facts
  • Launch date 02.12.2022 (3 years)
  • Number of Holdings 25
  • Strategy Passive (index tracking)
  • Base Currency USD
  • Currency hedging No
  • Distribution Policy Accumulating
  • Replication Method Physical
  • Securities lending No
  • Domicile IE
  • UCITS Compliant Yes

Price development

Error loading comparison.
There is not enough price data available for this period yet.

Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.

Risk figures (12 months)

No calculated risk figures are available for this fund yet.

The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.

Documents

We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.

Tracking difference and tracking error

We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.

What does the fund invest in?
As of 31.07.2026 · Source: justETF / etfdb
Sector Breakdown
  • Health care 100.0%
Country Breakdown
  • United States 69.1%
  • Ireland 10.1%
  • Switzerland 8.8%
  • United Kingdom 3.9%
  • Australia 2.8%
  • Italy 2.4%
  • Denmark 2.1%
  • Other 0.8%

Holdings

Showing 10 holdings that together make up 65.3 % of fund assets. (out of 25 holdings in total).

# Name ISIN Sector Country Weight
1 Medtronic Plc IE00BTN1Y115 – – 10.09 %
2 Stryker US8636671013 – – 10.00 %
3 Edwards Lifesciences Corp. US28176E1082 – – 9.49 %
4 Intuitive Surgical US46120E6023 – – 8.13 %
5 DexCom US2521311074 – – 7.36 %
6 Straumann Holding AG CH1175448666 – – 4.46 %
7 Sonova Holding AG CH0012549785 – – 4.34 %
8 Smith & Nephew plc US83175M2052 – – 3.94 %
9 Zimmer Biomet Holdings US98956P1021 – – 3.88 %
10 Glaukos US3773221029 – – 3.61 %
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?
Cost in year 1
–
Total cost impact
–

Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.

Alternatives on the same index
Other ETFs tracking the MVIS Global Bionic Healthcare ESG – cheapest first.
We know of no other ETFs tracking exactly this index.

Frequently asked questions about the VanEck Medical Robotics and Bionic Engineering UCITS ETF A

The total expense ratio (TER) of the VanEck Medical Robotics and Bionic Engineering UCITS ETF A is 0.55% per year. The costs are deducted from the fund assets on an ongoing basis and are already reflected in its performance.

The VanEck Medical Robotics and Bionic Engineering UCITS ETF A tracks the MVIS Global Bionic Healthcare ESG. Our index encyclopedia explains the index and lists all funds that track it.

The VanEck Medical Robotics and Bionic Engineering UCITS ETF A is accumulating: income such as dividends is not paid out but automatically reinvested in the fund.

The VanEck Medical Robotics and Bionic Engineering UCITS ETF A uses physical replication: it holds the securities of the index directly – either in full or as a representative sample (sampling).

The fund size of the VanEck Medical Robotics and Bionic Engineering UCITS ETF A is €11 m. A large fund size usually indicates good tradability and a lower risk of the fund being closed.

The VanEck Medical Robotics and Bionic Engineering UCITS ETF A is domiciled in Ireland. The fund domicile affects, among other things, how withholding taxes are treated inside the fund.

The provider (issuer) of the VanEck Medical Robotics and Bionic Engineering UCITS ETF A is VanEck.

All information without guarantee. It is provided for information purposes only and does not constitute investment advice.